Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Endocrine 1

Conditions

Neoplasms 2Spina Bifida Occulta 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Pain, Postoperative 1Neural Tube Defects 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lipomyelomeningocele 1Cerebrospinal Fluid Leak 1

Interventions

Bupivacaine 32Ropivacaine 19Dexmedetomidine 19Saline Solution 18Morphine 12Ketamine 12Sodium Chloride 10Acetaminophen 10Pregabalin 9Lidocaine 9Control Groups 9Injections, Epidural 5Dexamethasone 5Surgical Procedures, Operative 4Gabapentin 4Epinephrine 4Anesthetics, Local 4Anesthesia, General 4Analgesia, Patient-Controlled 4parecoxib 3oxycodone-acetaminophen 3Tea 3Midazolam 3Ketorolac 3Fentanyl 3Esketamine 3Dental Occlusion 3Anti-Inflammatory Agents, Non-Steroidal 3Analgesics, Opioid 3Vitamins 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain, Postoperative × Acetazolamide × Clear all
NCT04470843 2022-09-23

Impact of Acetazolamide in Reducing Referred Postoperative Pain

Medical College of Wisconsin

Phase 1 Completed
33 enrolled
EndocrineGenitourinary

Pain, Postoperative, Prostatic Neoplasms, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡